Development of a sensitive and specific in situ hybridization technique for the cellular localization of antisense

Nancy Goebl1, Brian Berridge, Victor J Wroblewski

  • 1Eli Lilly & Company, Drug Disposition Development/Commercialization. Indianapolis, IN 46285, USA. goebl_nancy_a@lilly.com

Toxicologic Pathology
|June 15, 2007
PubMed